Agoulnik IU - Search Results

1

Androgen Receptor and Poly(ADP-ribose) Glycohydrolase Inhibition Increases Efficiency of Androgen Ablation in Prostate Cancer Cells.

Zhang M, Lai Y, Vasquez JL, James DI, Smith KM, Waddell ID, Ogilvie DJ, Liu Y, Agoulnik IU. Zhang M, et al. Among authors: agoulnik iu. Sci Rep. 2020 Mar 2;10(1):3836. doi: 10.1038/s41598-020-60849-y. Sci Rep. 2020. PMID: 32123273 Free PMC article.

2

Repressors of androgen and progesterone receptor action.

Agoulnik IU, Krause WC, Bingman WE 3rd, Rahman HT, Amrikachi M, Ayala GE, Weigel NL. Agoulnik IU, et al. J Biol Chem. 2003 Aug 15;278(33):31136-48. doi: 10.1074/jbc.M305153200. Epub 2003 May 27. J Biol Chem. 2003. PMID: 12771131 Free article.

3

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.

Murthy S, Agoulnik IU, Weigel NL. Murthy S, et al. Among authors: agoulnik iu. Prostate. 2005 Sep 1;64(4):362-72. doi: 10.1002/pros.20251. Prostate. 2005. PMID: 15754350

4

Androgen receptor action in hormone-dependent and recurrent prostate cancer.

Agoulnik IU, Weigel NL. Agoulnik IU, et al. J Cell Biochem. 2006 Oct 1;99(2):362-72. doi: 10.1002/jcb.20811. J Cell Biochem. 2006. PMID: 16619264 Review.

5

Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.

Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE 3rd, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NL. Agoulnik IU, et al. Cancer Res. 2006 Nov 1;66(21):10594-602. doi: 10.1158/0008-5472.CAN-06-1023. Cancer Res. 2006. PMID: 17079484

6

Relaxin promotes prostate cancer progression.

Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI. Feng S, et al. Among authors: agoulnik ai, agoulnik iu. Clin Cancer Res. 2007 Mar 15;13(6):1695-702. doi: 10.1158/1078-0432.CCR-06-2492. Clin Cancer Res. 2007. PMID: 17363522

7

Androgen receptor coactivators and prostate cancer.

Agoulnik IU, Weigel NL. Agoulnik IU, et al. Adv Exp Med Biol. 2008;617:245-55. doi: 10.1007/978-0-387-69080-3_23. Adv Exp Med Biol. 2008. PMID: 18497048 Review. No abstract available.

8

Coactivator selective regulation of androgen receptor activity.

Agoulnik IU, Weigel NL. Agoulnik IU, et al. Steroids. 2009 Aug;74(8):669-74. doi: 10.1016/j.steroids.2009.02.007. Epub 2009 Mar 9. Steroids. 2009. PMID: 19463689 Free PMC article.

9

Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.

Feng S, Agoulnik IU, Truong A, Li Z, Creighton CJ, Kaftanovskaya EM, Pereira R, Han HD, Lopez-Berestein G, Klonisch T, Ittmann MM, Sood AK, Agoulnik AI. Feng S, et al. Among authors: agoulnik ai, agoulnik iu. Endocr Relat Cancer. 2010 Oct 29;17(4):1021-33. doi: 10.1677/ERC-10-0073. Print 2010 Dec. Endocr Relat Cancer. 2010. PMID: 20861284

10

Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, Ayala G, Ittmann MM, Weigel NL, Agoulnik IU. Hodgson MC, et al. Among authors: agoulnik iu. Cancer Res. 2011 Jan 15;71(2):572-82. doi: 10.1158/0008-5472.CAN-10-2314. Epub 2011 Jan 11. Cancer Res. 2011. PMID: 21224358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page